Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





COVID-19 Test Uses Novel High-Throughput Molecular Method for Detecting SARS-CoV-2 Infection in Saliva Samples

By LabMedica International staff writers
Posted on 30 Mar 2021
A new COVID-19 test uses a high-throughput molecular method for detecting infection by SARS-CoV-2 in specimens of saliva from individuals, allowing for fast and accurate detection of infection by the virus.

Escher Biomedical Diagnostics, LLC’s (Houston, TX, USA) Escher BT-MED COV19 Saliva Test has been accepted by FDA as a Notification under Section IV.C of the Emergency Use Authorization program. More...
The BT-MED COV19 Test system is a high-throughput molecular method for detecting infection by the SARS-CoV-2 virus in specimens of saliva from individuals suspected of COVID-19 by their healthcare provider. Escher intends to distribute the COVID-19 virus test in the US while FDA review of the EUA request is pending. At present, the BT-MED COV19 Test is for use only in CLIA-high-complexity laboratories.

The BT-MED system is composed of the BT-MED Analyzer and test kits associated with specific pathogens or panels of pathogens. The analyzer can be configured for full automated use, which minimizes the need for human technical activities, or partial automated use, which allows higher throughput. The BT-MED diagnostic device is based on in situ hybridization with fluorescent molecular probe, coupled with automated intelligent digital image processing that evaluates as to the presence or absence of the virus. There is no 'RT' and No 'PCR' because the BT-MED COV19 method uses alternate methods to amplify the signal due to the virus.

"We are pleased to introduce this important method to the detection and characterization of pathogens. The novel approach developed by Biotrack BV allows fast and accurate detection of the COVID-19 virus within infected human cells that appear in saliva," said Phil Speros of Escher. "And there are many advantages to saliva as a specimen, such as simplicity of collection, but also the ability to verify correct sample collection simply by observing the presence of the necessary small volume. These are important advantages over swab-based methods."

"After years of development our technology has come of age as a robust device that is simple to deploy and implement, even to challenging settings such as trucks and ships," said Gerard Schouten, CEO of Biotrack BV, the manufacturer of the test system. "Implementation in a clinical laboratory is easy. The fact that our system directly observes the molecular probe-lit viral nucleic acids in the infected human cells [shed in saliva] made it possible to create automated software to determine whether there is an infection or not."

Related Links:
Escher Biomedical Diagnostics, LLC


Gold Member
Multiplex Genetic Analyzer
MassARRAY Dx Analyzer (Europe only)
Collection and Transport System
PurSafe Plus®
New
Gold Member
Hematology Analyzer
Medonic M32B
New
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Left is the original cell image and right is same cell image zoomed in and rendered in the special imaging software (Photo courtesy of FIU)

Brain Inflammation Biomarker Detects Alzheimer’s Years Before Symptoms Appear

Alzheimer’s disease affects millions globally, but patients are often diagnosed only after memory loss and other symptoms appear, when brain damage is already extensive. Detecting the disease much earlier... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.